Related Experiment Video
Updated: May 25, 2026

07:23
Retinal Vascular Reactivity as Assessed by Optical Coherence Tomography Angiography
Published on: March 26, 2020
Optical coherence tomography findings in autoimmune retinopathy
Azin Abazari1, Souha S Allam, Grazyna Adamus
1Department of Ophthalmology, University of Virginia Health System, Charlottesville, Virginia, USA. azinabazari@gmail.com
American Journal of Ophthalmology
|January 17, 2012
Summary
Optical coherence tomography (OCT) reveals significant retinal atrophy and reduced macular thickness in autoimmune retinopathy patients. These OCT findings offer objective measures for diagnosing this condition and understanding vision loss mechanisms.
Area of Science:
- Ophthalmology
- Medical Imaging
- Immunology
Background:
- Autoimmune retinopathy (AIR) is an immune-mediated condition causing progressive vision loss.
- Diagnosis often relies on clinical presentation, electroretinography (ERG), and antibody testing.
- Objective imaging biomarkers are crucial for understanding disease progression.
Purpose of the Study:
- To characterize the optical coherence tomography (OCT) findings in patients diagnosed with autoimmune retinopathy.
- To correlate OCT features with clinical manifestations of vision impairment.
Main Methods:
- A consecutive case series of eight patients with unexplained vision loss was analyzed.
- All patients underwent macular and nerve fiber layer (NFL) OCT.
- Diagnosis of AIR was confirmed by clinical features, ERG, and serum antiretinal antibodies.
Main Results:
- All patients exhibited outer retinal abnormalities and/or reduced macular thickness on OCT.
- Six patients showed decreased central macular and foveal thickness.
- Photoreceptor layer disruption was observed in most patients, with some showing NFL loss.
Conclusions:
- Optical coherence tomography demonstrates predominant retinal atrophy and reduced macular thickness in autoimmune retinopathy.
- OCT provides objective, quantifiable data on retinal damage in AIR.
- OCT findings may aid in diagnosing autoimmune retinopathy and elucidating visual dysfunction mechanisms.
